SMS Pharmaceuticals clears USFDA inspection at Vizag API plant with one minor observation
1 min read

SMS Pharmaceuticals clears USFDA inspection at Vizag API plant with one minor observation

farman.mansoori.ff@gmail.com0

SMS Pharmaceuticals Ltd completes USFDA inspection at Visakhapatnam API facility with minor observation, reinforcing global quality and compliance standards. Shares of SMS Pharmaceuticals Ltd ended lower on Friday, December 12, by 0.23% at ₹320.15 on the NSE.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Website http://newswave.blog

Related Posts